Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers

NCT02264990 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

595

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-squamous Non-small Cell Lung Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Veliparib
DRUG: Pemetrexed

Sponsor

AbbVie